HCS Pharma

📍 LOOS, France🗓 Founded 2014👥 21 employees💰 Last funded Apr 2022
Biotechnology Research🌐 hcs-pharma.com
Website LinkedIn
HCS Pharma is a biotechnology company focused on in vitro R&D, specializing in high content (HCA) and high throughput (HCS) cell imaging screening. HCS Pharma sells products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® extracellular matrix. BIOMIMESYS® 3D culture technology faithfully reproduces the natural microenvironment of cells in 3D, to ensure more predictive results from in vitro studies, to reduce the time and cost of R&D, and animal testing in pharmaceutical, nutraceutical and cosmetic companies. HCS is a multi-parametric imaging system, which allows to gain time and money by following several parameters within the same experiment. We can perform proof of concept / mechanism of action assays, assay development and primary or secondary screenings for you. We develop our own models that we offer for services in different fields (Toxicology, Pharmacology, Dermocosmetic), our own compound libraries (Prestwick, ENZO, ELF…), and our own innovative and exclusive 3D technology BIOMIMESYS® biofunctionalized scaffold for innovative phenotypic screening model. We are located on the Eusanté Park in Loos (close to Lille)
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in HCS Pharma?
HCS Pharma has 1 investors on record on gritt.io and 1 late-stage investors.
When did HCS Pharma last raise funding?
The most recent investment in HCS Pharma recorded on gritt.io was in April 2022.
When was HCS Pharma founded?
HCS Pharma was founded in 2014.
What industry is HCS Pharma in?
HCS Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HCS Pharma based?
HCS Pharma is headquartered in LOOS, France.